Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5953
|
pubmed:dateCreated |
1975-5-21
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0007-1447
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
331
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1111802-Adult,
pubmed-meshheading:1111802-Basal Ganglia Diseases,
pubmed-meshheading:1111802-Face,
pubmed-meshheading:1111802-Facial Expression,
pubmed-meshheading:1111802-Female,
pubmed-meshheading:1111802-Humans,
pubmed-meshheading:1111802-Male,
pubmed-meshheading:1111802-Metoclopramide,
pubmed-meshheading:1111802-Movement Disorders
|
pubmed:year |
1975
|
pubmed:articleTitle |
Letter: Metoclopramide and facial dyskinesia.
|
pubmed:publicationType |
Journal Article
|